Targeted therapies: summary clinical trials working group.
作者信息
Weinblatt M E, van Riel P L C M
机构信息
Brigham and Women's Hospital, Boston, MA, USA.
出版信息
Ann Rheum Dis. 2006 Nov;65 Suppl 3(Suppl 3):iii89. doi: 10.1136/ard.2006.060939.
Abstract
摘要
相似文献
1
Targeted therapies: summary clinical trials working group.靶向治疗：临床总结试验工作组
Ann Rheum Dis. 2006 Nov;65 Suppl 3(Suppl 3):iii89. doi: 10.1136/ard.2006.060939.
2
Add-on or step-up trials for new drug development in rheumatoid arthritis: a new standard?类风湿关节炎新药研发中的附加治疗或递进式试验：一种新标准？
Arthritis Rheum. 2003 Jun;48(6):1481-3. doi: 10.1002/art.11141.
3
Add-on or step-up trials in rheumatoid arthritis: comment on the article by Boers.类风湿关节炎的附加治疗或逐步升级试验：对博尔斯文章的评论
Arthritis Rheum. 2004 Apr;50(4):1351; author reply 1351-2. doi: 10.1002/art.20161.
4
Combination treatment in autoimmune diseases. Methodology of combination trials.
Springer Semin Immunopathol. 2001;23(1-2):27-33. doi: 10.1007/s002810100073.
5
It is the best of times; it is the worst of times: is there a way forward? A plethora of treatment options for rheumatoid arthritis, but critical trial design issues.这是最好的时代；这是最坏的时代：有前进的道路吗？类风湿关节炎有大量的治疗选择，但存在关键的试验设计问题。
Arthritis Rheum. 2007 Dec;56(12):3884-6. doi: 10.1002/art.23140.
6
Failure to report previously used drugs and dosages in pharmaceutical company-sponsored rheumatoid arthritis trials: comment on the article by Yocum et al.制药公司赞助的类风湿性关节炎试验中未报告先前使用的药物和剂量：对Yocum等人文章的评论
Arthritis Rheum. 2004 Sep;50(9):3051; author reply 3051-2. doi: 10.1002/art.20642.
7
The horseless carriage: moving forward with the hybrid ACR.
Arthritis Rheum. 2007 Mar 15;57(2):189-90. doi: 10.1002/art.22550.
8
The design of clinical trials aimed at assessing the DC-ART properties of new molecules in rheumatoid arthritis.
Clin Exp Rheumatol. 1997 May-Jun;15 Suppl 17:S39-44.
9
Statistical considerations concerning clinical studies designed to assess DC-ARTs.关于旨在评估直接作用抗病毒治疗（DC-ARTs）的临床研究的统计学考量。
Clin Exp Rheumatol. 1997 May-Jun;15 Suppl 17:S45-52.
10
Therapeutic strategies for rheumatoid arthritis.类风湿关节炎的治疗策略
Nat Rev Drug Discov. 2003 Jun;2(6):473-88. doi: 10.1038/nrd1109.
引用本文的文献
1
Metabolic Control of Autoimmunity and Tissue Inflammation in Rheumatoid Arthritis.类风湿关节炎中自身免疫和组织炎症的代谢控制
Front Immunol. 2021 Apr 2;12:652771. doi: 10.3389/fimmu.2021.652771. eCollection 2021.
2
The interplay between inflammation and metabolism in rheumatoid arthritis.类风湿关节炎中炎症与代谢的相互作用。
Cell Death Dis. 2015 Sep 17;6(9):e1887. doi: 10.1038/cddis.2015.246.
3
Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab.甲氨蝶呤和抗 TNF-α 英夫利昔单抗治疗后人类 CD4+ 细胞的代谢组学分析。
Cell Cycle. 2013 Sep 15;12(18):3025-36. doi: 10.4161/cc.26067. Epub 2013 Aug 19.
Zotero 插件